June 1, 2024Open Access

Predictive factors for peripheral blood stem cell mobilization in multiple myeloma in the era of novel therapies: A single‐center experience

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Multiple myeloma (MM) is the leading indication of autologous hematopoietic stem cell transplantation. The aim of this study was to determine the incidence of mobilization failure and characterize the risk factors associated with poor mobilization (PM) of MM patients in novel therapies era.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Xiao et al. (Sat,) studied this question.

synapsesocial.com/papers/68e66b2fb6db6435875f6bb0 https://doi.org/https://doi.org/10.1002/cam4.7356

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Factors affecting stem cell mobilization for autologous hematopoietic stem cell transplantation2010 · 57 citations
2Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study2019 · 956 citations
3The future of autologous stem cell transplantation in myeloma2014 · 51 citations
4Cost-Effectiveness Analysis of a Risk-Adapted Algorithm of Plerixafor Use for Autologous Peripheral Blood Stem Cell Mobilization2012 · 87 citations
5Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization2021 · 42 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo